Inhibitory effects of Dioscin on atherosclerosis and foam cell formation in hyperlipidemia rats

Low dose tunicamycin enhances atherosclerotic plaque stability by inducing autophagy

(2016) Meijuan Ma et al.   BIOCHEMICAL PHARMACOLOGY

From Lipids to Inflammation

(2016) Michael D. Shapiro et al.   CIRCULATION RESEARCH

Impact of Macrophages in Atherosclerosis

(2016) Xinjie Lu   CURRENT MEDICINAL CHEMISTRY

Atherosclerosis — do we know enough already to prevent it?

(2016) Chandrakala Aluganti Narasimhulu et al.   CURRENT OPINION IN PHARMACOLOGY

Potent effects of dioscin against gastric cancer in vitro and in vivo

(2016) Xinwei Zhao et al.   PHYTOMEDICINE

Potent anti-inflammatory effect of dioscin mediated by suppression of TNF-α-induced VCAM-1, ICAM-1and EL expression via the NF-κB pathway

(2015) Shan Wu et al.   BIOCHIMIE

Rapid emergence of atherosclerosis in Asia

(2015) Martin C.S. Wong et al.   CURRENT OPINION IN LIPIDOLOGY

MicroRNA-101 overexpression by IL-6 and TNF-α inhibits cholesterol efflux by suppressing ATP-binding cassette transporter A1 expression

(2015) Nan Zhang et al.   EXPERIMENTAL CELL RESEARCH

Dioscin ameliorates cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via HMGB-1 inhibition

(2015) Xufeng Tao et al.   FREE RADICAL BIOLOGY AND MEDICINE

Captopril inhibits maturation of dendritic cells and maintains their tolerogenic property in atherosclerotic rats

(2015) Hong-qi Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

RIP140 contributes to foam cell formation and atherosclerosis by regulating cholesterol homeostasis in macrophages

(2015) Yi-Wei Lin et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Chemokines and their receptors in Atherosclerosis

(2015) Emiel P. C. van der Vorst et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Dioscin attenuates renal ischemia/reperfusion injury by inhibiting the TLR4/MyD88 signaling pathway via up-regulation of HSP70

(2015) Meng Qi et al.   PHARMACOLOGICAL RESEARCH

Potent effects of dioscin against obesity in mice

(2015) Min Liu et al.   Scientific Reports

Dioscin alleviates alcoholic liver fibrosis by attenuating hepatic stellate cell activation via the TLR4/MyD88/NF-κB signaling pathway

(2015) Min Liu et al.   Scientific Reports

Inhibitory effects of Mycoepoxydiene on macrophage foam cell formation and atherosclerosis in ApoE-deficient mice

(2015) Xiaochun Xia et al.   Cell and Bioscience

MicroRNA-27a/b regulates cellular cholesterol efflux, influx and esterification/hydrolysis in THP-1 macrophages

(2014) Min Zhang et al.   ATHEROSCLEROSIS

Dioscin inhibits adipogenesis through the AMPK/MAPK pathway in 3T3-L1 cells and modulates fat accumulation in obese mice

(2014) BARUN POUDEL et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

BMP4 Enhances Foam Cell Formation by BMPR-2/Smad1/5/8 Signaling

(2014) Jun Feng et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

oxLDL/β2GPI/anti-β2GPI complex induced macrophage differentiation to foam cell involving TLR4/NF-kappa B signal transduction pathway

(2014) Ya Xu et al.   THROMBOSIS RESEARCH

Dioscin Attenuates Hepatic Ischemia-Reperfusion Injury in Rats Through Inhibition of Oxidative-Nitrative Stress, Inflammation and Apoptosis

(2014) Xufeng Tao et al.   TRANSPLANTATION

Dioscin inhibits osteoclast differentiation and bone resorption though down-regulating the Akt signaling cascades

(2013) Xinhua Qu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36

(2013) Fenghua Zhou et al.   CELL STRESS & CHAPERONES

Dioscin Restores the Activity of the Anticancer Agent Adriamycin in Multidrug-Resistant Human Leukemia K562/Adriamycin Cells by Down-Regulating MDR1 via a Mechanism Involving NF-κB Signaling Inhibition

(2013) Lijuan Wang et al.   JOURNAL OF NATURAL PRODUCTS

Influence of different particle processing on hypocholesterolemic and antiatherogenic activities of yam (Dioscorea pseudojaponica) in cholesterol-fed rabbit model

(2013) Chun-Hsu Pan et al.   JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE

LOX-1, OxLDL, and Atherosclerosis

(2013) Angela Pirillo et al.   MEDIATORS OF INFLAMMATION

LOX-1 in atherosclerosis: biological functions and pharmacological modifiers

(2012) Suowen Xu et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Current Concepts of the Role of Oxidized LDL Receptors in Atherosclerosis

(2012) Tanu Goyal et al.   Current Atherosclerosis Reports

Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors

(2012) Misato Hashizume et al.   CYTOKINE

Mechanism investigation of dioscin against CCl 4 -induced acute liver damage in mice

(2012) Binan Lu et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY

Monoclonal antibodies targeting IL-1 beta reduce biomarkers of atherosclerosis in vitro and inhibit atherosclerotic plaque formation in Apolipoprotein E-deficient mice

(2011) Vinay Bhaskar et al.   ATHEROSCLEROSIS

Macrophages in the Pathogenesis of Atherosclerosis

(2011) Kathryn J. Moore et al.   CELL

The nuclear factor – kappa B pathway in atherosclerosis: A potential therapeutic target for atherothrombotic vascular disease

(2011) Burak Pamukcu et al.   THROMBOSIS RESEARCH

Danshensu protects vascular endothelia in a rat model of hyperhomocysteinemia

(2010) Rui-xue Yang et al.   ACTA PHARMACOLOGICA SINICA

Overexpression of scavenger receptor LOX-1 in endothelial cells promotes atherogenesis in the ApoE−/− mouse model

(2010) Stephen J. White et al.   CARDIOVASCULAR PATHOLOGY

Mechanisms of liver disease: cross-talk between the NF-κB and JNK pathways

(2009) Salvatore Papa et al.   BIOLOGICAL CHEMISTRY

Lysyl oxidase (LOX) down-regulation by TNFα: A new mechanism underlying TNFα-induced endothelial dysfunction

(2007) C. Rodríguez et al.   ATHEROSCLEROSIS